These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6408192

  • 21. [Preventive chemotherapy of superficial tumors of the bladder].
    Zungri E, Gill A, Algaba F.
    J Urol (Paris); 1986; 92(1):39-41. PubMed ID: 3722852
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Local mitomycin-C therapy in relapse-prevention of superficial bladder neoplasms treated by means of laser.
    Szemes Z, Kovács R.
    Acta Chir Hung; 1994; 34(1-2):5-10. PubMed ID: 7604628
    [Abstract] [Full Text] [Related]

  • 24. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.
    Giannopoulos A, Constantinides C, Fokaeas E, Stravodimos C, Giannopoulou M, Kyroudi A, Gounaris A.
    Clin Cancer Res; 2003 Nov 15; 9(15):5550-8. PubMed ID: 14654535
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
    Rodrigues Netto Júnior N, Lemos GC.
    J Urol; 1983 Jan 15; 129(1):33-4. PubMed ID: 6402610
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A 12 versus 6-week course of bacillus Calmette-Guerin prophylaxis for the treatment of high risk superficial bladder cancer.
    Gruenwald IE, Stein A, Rashcovitsky R, Shifroni G, Lurie A.
    J Urol; 1997 Feb 15; 157(2):487-91. PubMed ID: 8996340
    [Abstract] [Full Text] [Related]

  • 32. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa.
    Prout GR, Koontz WW, Coombs LJ, Hawkins IR, Friedell GH.
    J Urol; 1983 Oct 15; 130(4):677-80. PubMed ID: 6411939
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma].
    Kanematsu A, Tsuji Y, Kanba H, Noguchi T, Kamoto T, Okabe T.
    Hinyokika Kiyo; 2001 Jan 15; 47(1):1-4. PubMed ID: 11235213
    [Abstract] [Full Text] [Related]

  • 38. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
    Rivera P, Caffarena E, Cornejo H, Del Pino M, Fonerón A, Haemmersli J, Sepúlveda M, Ubilla A.
    Actas Urol Esp; 1993 Apr 15; 17(4):243-6. PubMed ID: 8342414
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment.
    Okamura T, Akita H, Imura M, Kaneko T, Mizuno K, Tozawa K, Kohri K.
    Int J Urol; 2008 Oct 15; 15(11):976-80. PubMed ID: 18721199
    [Abstract] [Full Text] [Related]

  • 40. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
    Mauroy B, Bonnal JL, Prevost B, Chive M, Lhotellier V, Sozanski JP, Vanseymortier L, Stefaniak X.
    Prog Urol; 1999 Feb 15; 9(1):69-80. PubMed ID: 10212955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.